Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Reproductive Sciences
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sheffield, J. S.
Right arrow Articles by Norgard, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheffield, J. S.
Right arrow Articles by Wendel, G. D., Jr
Right arrow Articles by McIntire, D. D.
Right arrow Articles by Norgard, M. V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*PROGESTERONE
Medline Plus Health Information
*High Risk Pregnancy
*Infections and Pregnancy
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Effect of Progesterone Levels and Pregnancy on HIV-1 Coreceptor Expression

Jeanne S. Sheffield, MD

Departments of Obstetrics and Gynecology University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, Jeanne.Sheffield@ utsouthwestern.edu

George D. Wendel, Jr, MD

Departments of Obstetrics and Gynecology University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Donald D. McIntire, PhD

Departments of Obstetrics and Gynecology University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Michael V. Norgard, PhD

Department of Microbiology University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

The upregulation of HIV-1 co-receptor expression during certain clinical settings may explain the predisposition of individuals to enhanced HIV-1 acquisition. We sought to determine the effect of estrogen and progesterone on the HIV-1 coreceptors, CCR5 and CXCR4. Co-receptor expression on CD3- and CD14-positive cells obtained systemically and locally (genital tissue in women) was determined in men, pre- and post-menopausal women, pregnant women in each trimester and in labor. CCR5 on both CD3- and CD14-positive cells was highest in pregnant women, and increased as gestation advanced ( P < .01 and P < .001, respectively). Progesterone levels were significantly associated with CCR5 expression on PBMCs ( P < .03 for CD3-positive, and P < .002 for CD14-positive cells) and from cells isolated from tissue ( P < .001).CCR5 mRNA expression correlated with the cell surface marker expression from blood and tissue. These findings suggest that pregnancy and other high progesterone states may predispose women to HIV-1 acquisition.

Key Words: Progesterone • HIV acquisition • HIV-1 coreceptor.

Reproductive Sciences, Vol. 16, No. 1, 20-31 (2009)
DOI: 10.1177/1933719108325510


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?